Skip to main content

Peer Review reports

From: Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model

Original Submission
25 Jun 2020 Submitted Original manuscript
25 Jul 2020 Reviewed Reviewer Report
29 Jul 2020 Reviewed Reviewer Report
26 Aug 2020 Author responded Author comments - Christian Linke
Resubmission - Version 2
26 Aug 2020 Submitted Manuscript version 2
8 Sep 2020 Author responded Author comments - Christian Linke
Resubmission - Version 3
8 Sep 2020 Submitted Manuscript version 3
Publishing
9 Sep 2020 Editorially accepted
18 Sep 2020 Article published 10.1186/s12885-020-07397-w

You can find further information about peer review here.

Back to article page